Announcements Trials
Browse Landscape

Status

No longer available 2

Sponsor Class

INDUSTRY 10OTHER 2

Study Type

Interventional 1155Observational 200Expanded_access 2

Sponsor

Cancer Type

Genitourinary 20CNS 18Gastrointestinal 16Other hematologic neoplasm 14Sarcoma 12Endocrine 11Lymphoid 9Plasma cell 7Tumor-Agnostic 6Myeloid 6Breast 5NET 4Head & Neck 4Thoracic 3Other neoplasm 3Other solid neoplasm 2Gynecologic 2Dermatologic 2Classical hematology 2

Conditions

Wilms Tumor 1Solid Tumor, Adult 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Expanded_access × Other solid neoplasm × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT03914872 2024-03-12

Expanded Access Neoantigen Vaccine in Solid Tumors

Washington University School of Medicine

No longer available
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡